Outcomes of 385 Adult-to-Adult Living Donor Liver Transplant Recipients
Kim M. Olthoff(University of Pennsylvania), Jean C. Emond(Columbia University Irving Medical Center), Timothy L. Pruett(University of Minnesota), Chris E. Freise(University of California, San Francisco), Brenda W. Gillespie(University of Michigan–Ann Arbor), James E. Everhart(Memorial Health University Medical Center), Michaël Abécassis(University of Arizona), Robert A. Fisher(University of Connecticut), Tempie E. Hulbert‐Shearon(University of Colorado Denver), Igal Kam(University of Colorado Denver), Jeffrey H. Fair(The University of Texas Health Science Center), Rafik M. Ghobrial, Robert M. Merion(University of Kansas Medical Center)
Cited by 352
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
|Liver Transplantation|2010|1.2k